Consultation: sulfasalazine paediatric shared care protocol

We now seek comments on a draft shared care protocol for sulfasalazine for patients in paediatric services. The document covers use in ulcerative colitis and active Crohn’s disease.

All comments will be reviewed but please do not expect a personal reply as we do not routinely reply to all comments. It is important to include any relevant evidence to back up any suggestions and please keep comments concise where possible.

Please note

1. So your comment can be fully actioned, your contact information may be shared with the authors of the consultation document, or with members of GMMMG or its subgroups.
2. This consultation will run for six weeks and closes at 5pm on Friday 11^th September 2026.

Name *

Email *

Email

Confirm Email

Your job title *

Your employer *

Locality

Are you responding on behalf of an organisation or as an individual? *

• On behalf of an organisation or organisational leader
• As an individual

Please specify who you are responding for, including job title and organisation as appropriate *

Do you support implementation of the shared care protocol? *

• Yes
• No (please provide detail below)
• In part (please provide detail below)

If no or "in part", please explain why

Do you have any additional comments?

Submit